Patient identifier complete entry = (b)(6).All available patient information was included.Additional patient details are not available.The complaint investigation for falsely elevated patient results when using alinity c carbon dioxide, lot number 57109uq03, and alinity c carbon dioxide calibrator, lot number 86176fd01, included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.Trending review determined no related trend for the product.Manufacturing documentation for the likely cause lots were reviewed and did not identify any issues.Device history record review on lot numbers 57109uq03 and 86176fd01 did not identify any non-conformances or deviations with the likely cause lots.Labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the alinity c carbon dioxide assay was identified.Based on the information provided and abbott diagnostics¿ complaint investigation, no systemic issue or deficiency of alinity c carbon dioxide was identified.
|
The customer observed falsely elevated alinity c carbon dioxide results for six patients.The following data was provided: sample id (b)(6) initial result was 30, repeat after recalibration was 27 mmol/l.Sample id (b)(6) initial result was 30, repeat after recalibration was 27 mmol/l.Sample id (b)(6) initial result was 30, repeat after recalibration was 27 mmol/l.Sample id (b)(6) initial result was 30, repeat after recalibration was 27 mmol/l.Sample id (b)(6) initial result was 31, repeat after recalibration was 28 mmol/l.Sample id (b)(6) initial result was 30, repeat after recalibration was 27 mmol/l.There was no impact to patient management reported.
|